1 류종훈, "한방약리학" 신일상사 2006
2 이해남, "한국 여성의 요골 골밀도치에 의한 골다공증의 빈도 및 폐경에 따른 변화" 대한산부인과학회 45 (45): 12-12, 2002
3 김민정, "하수오와 백수오가 난소적출로 유발된 흰쥐의 골다공증 예방효과에 미치는 영향" 대한본초학회 19 (19): 23-34, 2004
4 조수현, "폐경과 골다공증" 35 : 587-598, 1992
5 대한정형외과학회, "정형외과학" 최신의학사 13-14, 1992
6 강세윤, "오늘의 진단 및 치료(Current Medical Diagnosis & Treatment)" 도서출판 한우리 1218-, 1999
7 강소신의학원, "신편중약대사전" 의성당 862-865, 1992
8 이동선, "두충[Eucommia ulmoides Oliver.] 조성물이 골다공증에 미치는 효과" 16 : 614-619, 2001
9 "도설한방의학대사전.중국약학대전3" 인민위생출판사 124-127, 1991
10 지형준, "대한약전 및 대한약전외 한약규격주해" 한국메디칼 인덱스사 266-267, 1998
1 류종훈, "한방약리학" 신일상사 2006
2 이해남, "한국 여성의 요골 골밀도치에 의한 골다공증의 빈도 및 폐경에 따른 변화" 대한산부인과학회 45 (45): 12-12, 2002
3 김민정, "하수오와 백수오가 난소적출로 유발된 흰쥐의 골다공증 예방효과에 미치는 영향" 대한본초학회 19 (19): 23-34, 2004
4 조수현, "폐경과 골다공증" 35 : 587-598, 1992
5 대한정형외과학회, "정형외과학" 최신의학사 13-14, 1992
6 강세윤, "오늘의 진단 및 치료(Current Medical Diagnosis & Treatment)" 도서출판 한우리 1218-, 1999
7 강소신의학원, "신편중약대사전" 의성당 862-865, 1992
8 이동선, "두충[Eucommia ulmoides Oliver.] 조성물이 골다공증에 미치는 효과" 16 : 614-619, 2001
9 "도설한방의학대사전.중국약학대전3" 인민위생출판사 124-127, 1991
10 지형준, "대한약전 및 대한약전외 한약규격주해" 한국메디칼 인덱스사 266-267, 1998
11 김덕윤, "골형성의 생화학적 표지자" 1 : 233-239, 1994
12 박근용, "골다공증의 진단 및 치료에서 생화학적 표지자의 응용" 29 : 1995
13 서규태, "生何首烏와 製何首烏가 卵巢摘出로 유발된 흰쥐의 骨多孔症 예방효과에 미치는 영향" 대한본초학회 20 (20): 137-148, 2005
14 Suda T, "osteoclast generation, In Principles of Bone Biology" Academic Press 87-, 1996
15 Jimi E, "osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function" 163 : 434-442, 1999
16 Lee SE, "Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK" 276 : 49343-49349, 2001
17 Rodan GA, "Therapeutic approaches to bone diseases" 289 : 1508-1514, 2000
18 Benayahu D, "The hematopoietic microenvironment: The osteogenic compartment of bone marrow: Cell biology and clinical application" 4 : 427-435, 2000
19 GeonseekRyu, "The Radical Scavenging Effects of Stilbene Glucosides from Polygonum multiflorum" 대한약학회 25 (25): 636-639, 2002
20 Komori T, "Targeted disruption of Cbfa-1 results in a complete lack of bone formation owing to matureational arrest of osteoblasts" 89 : 755-764, 1997
21 Gittens SA, "Systemic bone formation with weekly PTH administration in ovariectomized rats" 7 : 27-37, 2004
22 JaeHyun Lee, "Single Subcutaneous Dose Toxicity of Polycan?, a β-Glucan Originated from Aureobasidium in Mice" 한국실험동물학회 21 (21): 299-305, 2005
23 Weinreb M, "Short-term healing kinetics of cortical and cancellous bone osteopenia induced by unloading during the reloading period in young rats" 431 : 449-452, 1997
24 Komori T, "Requisite roles of Runx2 and Cbfa in skeletal development" 21 : 193-197, 2003
25 Andersson N, "Repeated in vivo determinations of bone mineral density during parathyroid hormone treatment in ovariectomized mice" 170 : 529-537, 2001
26 Stein GS, "Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation" 4 : 3111-3123, 1990
27 Suda T, "Regulation of osteoclast function" 12 : 869-879, 1997
28 Aubin JE, "Regulation of osteoblast formation and function" 2 : 81-94, 2001
29 Yamaguchi A, "Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa-1" 21 : 393-411, 2000
30 Chen K, "Recent advances in studies on traditional Chinese anti-aging material medication" 13 : 223-226, 1993
31 Li M, "Protective effect of polygonum multiflorum thunb on the cerebral cholinergic neurofibers in rats" 28 : 361-364, 2003
32 Gingery A, "Phosphatidylinositol 3-kinase coordinately activates the MEK/ERK and AKT/NFkB pathways to maintain osteoclast survival" 89 : 165-169, 2003
33 정경채, "Momordin I, an inhibitor of AP-1, suppressed osteoclastogenesis through inhibition of NF-kappa B and AP-1 and also reduced osteoclast activity and survival" 337 : 815-823, 200511
34 Ke HZ, "Longterm treatment of lasofoxifene preserves bone mass and bone strength and dose not adversely affect the uterus in ovariectomized rats" 145 : 1996-2005, 2004
35 Xiao PG, "Immunological aspects of Chinese medicinal plants as antiageing drugs" 38 : 167-175, 1993
36 Alexander JM, "Human parathyroid hormone 1-34 reverses bone loss in ovariectomized mice" 16 : 1665-1673, 2001
37 Li R, "Hormone replacement therapy and breast carcinoma risk in Hispanic and non-Hispanic women" 95 : 960-968, 2002
38 Gowen M, "Emerging therapies for osteoporosis" 5 : 1-43, 2000
39 Pytlik M, "Effects of tibolone on the development of osteopenia induced by ovariectomy in rats" 54 : 35-43, 2002
40 Lauritzen DB, "Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats" 8 : 871-879, 1993
41 Ladizesky MG, "Effect of melatonin on bone metabolism in ovariectomized rats" 70 : 557-565, 2001
42 Wronski TJ, "Effect of body weight on osteopenia in ovariectomized rats" 40 : 155-159, 1987
43 Wang W, "Effect of alcoholic extract of prepared radix Polygoni multiflori on preventing atherosclerosis in Japanese quail" 4 : 748-750, 1984
44 Joseph, M. L., "Current concepts review osteoporosis" 223-224, 1983
45 Chen D, "Bone morphogenetic proteins" 22 : 233-241, 2004
46 Noble B, "Bone microdamage and cell apoptosis" 6 : 45-56, 2003
47 Sakai A, "Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice" 23 : 443-451, 1998
48 Kim HJ, "Bombycis corpus extract prevents amyloid-beta-induced cytotoxicity and protects superoxide dismutase activity in cultured rat astrocytes" 43 : 11-16, 2001